NCT01532505

Brief Summary

The objective of this research is to compare the effect of a low dose Vasopressin infusion or placebo during cardiopulmonary bypass on vasopressor requirements, hemodynamics and tissue oxygen saturation and its recovery using tNIRS and vascular occlusion test (VOT) in elective on pump cardiac surgery patients using a non-invasive near infrared spectrometry (NIRS) machine. The clinical implications are that NIRS may permit earlier, non-invasive detection of significant physiologic derangements and allow more accurate and timely titration of medications, fluids and surgical intervention. The use of a low dose vasopressin seems to be preventive for the incidence of observed post-cardiotomy vasodilatory shock and may improve the function of microcirculation that will be assessed using VOT and tNIRS. Finally, it may decrease both catecholamine dose and duration of their administration, it is considered as a useful agent for decreasing all heir side-effects

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
40

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Feb 2012

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

January 19, 2012

Completed
13 days until next milestone

Study Start

First participant enrolled

February 1, 2012

Completed
13 days until next milestone

First Posted

Study publicly available on registry

February 14, 2012

Completed
10 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2012

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2012

Completed
Last Updated

February 15, 2012

Status Verified

February 1, 2012

Enrollment Period

10 months

First QC Date

January 19, 2012

Last Update Submit

February 13, 2012

Conditions

Keywords

cardiopulmonary bypassPostcardiotomy vasodilatory shockMicrocirculationCatecholaminesVasopressin

Outcome Measures

Primary Outcomes (1)

  • VOT assessment of microcirculation

    change in reperfusion slope of VOT will be assessed each 30 min during CPB and compared between vasopressin and placebo patients

    day one

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Stable patients coming from home for elective cardiac surgery are eligible to participate

You may qualify if:

  • Adult, elective cardiac surgery patients with the use of cardiopulmonary bypass (CPB)

You may not qualify if:

  • Age less than 18 years
  • Contraindication to pneumatic cuff inflation (arteriovenous fistula, previous mastectomy, injury to arm)
  • Pregnancy
  • Significant peripheral vascular disease of the arms\*
  • Emergency surgery
  • Uncured cancer during chemotherapy
  • Lack of informed consent

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University Hospital, LHSC

London, Ontario, N6A 5A5, Canada

Location

Related Publications (2)

  • Peripheral Tissue Oxygen Saturation (SaO2) Monitoring and the Vascular Occlusion Test in Cardiac Surgery: A Pilot Study. Smith R, Murkin J, Granton J, Guo LR, McKenzie FN, Min F, Zhang R. ASA Chicago, Oct 15-19, 2011, Anesthesiology 2011 A278.

    BACKGROUND
  • Papadopoulos G, Sintou E, Siminelakis S, Koletsis E, Baikoussis NG, Apostolakis E. Perioperative infusion of low- dose of vasopressin for prevention and management of vasodilatory vasoplegic syndrome in patients undergoing coronary artery bypass grafting-A double-blind randomized study. J Cardiothorac Surg. 2010 Mar 28;5:17. doi: 10.1186/1749-8090-5-17.

    PMID: 20346182BACKGROUND

MeSH Terms

Conditions

HypotensionDiabetes Insipidus

Condition Hierarchy (Ancestors)

Vascular DiseasesCardiovascular DiseasesKidney DiseasesUrologic DiseasesFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesMale Urogenital DiseasesPituitary DiseasesEndocrine System Diseases

Study Officials

  • MOHAMED ISMAIL, MD,MSc

    London HSC

    PRINCIPAL INVESTIGATOR
  • JOHN MURKIN, MD, FRCPC

    London HSC

    STUDY DIRECTOR

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Principal investigator

Study Record Dates

First Submitted

January 19, 2012

First Posted

February 14, 2012

Study Start

February 1, 2012

Primary Completion

December 1, 2012

Study Completion

December 1, 2012

Last Updated

February 15, 2012

Record last verified: 2012-02

Locations